Sanofi expands Regeneron partnership with up to $8 billion deal in win for new CEO

1

Oct 1 (Reuters) – Sanofi and US partner Regeneron on Thursday said they would expand their partnership to develop four new drugs, in a deal that includes up to $7 billion in milestone payments. Sanofi

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)